Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

genomics

Genomics appoints Sekar Kathiresan as scientific advisory board chair

January 11, 2016 Sales and Marketing genomics

Genomics has appointed Dr Sekar Kathiresan as chair of the company’s newly-formed scientific advisory board as chair, with immediate effect. Dr …
Appointment

Shire and Baxalta reach $32 billion merger agreement

January 11, 2016 Manufacturing and Production, Sales and Marketing Baxalta, Shire, mergers, mergers and acquisitions

One of the industry’s longest-running M&A sagas has finally reached a conclusion, with Shire and Baxalta announcing a $32 billion …
News

AbbVie begins late stage trials of rheumatoid arthritis drug

January 11, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ABT-494, AbbVie, F-star, JAK-1 inhibitor, rheumatoid arthritis

AbbVie has begun a large phase III clinical trial programme for its next-generation rheumatoid arthritis (RA) treatment ABT-494, which the …
News
Elias Zerhouni

Sanofi seals double oncology research deals

January 11, 2016 Research and Development, Sales and Marketing Sanofi, Warp Drive Bio, antibodies, collaboration, immuno-oncology, research

Sanofi has signed two separate research agreements for €1.2 billion, which will give the French firm licensing rights to potential …
News
novartis_window

Novartis expands immuno-oncology programme

January 11, 2016 Research and Development, Sales and Marketing Cancer, Novartis, Surface Oncology, collaboration, immuno-oncology

Novartis has further bolstered its immuno-oncology pipeline through a strategic alliance and licensing agreement with Surface Oncology, as it moves …
News
GSK logo

GSK explains decision to halt payments to doctors

January 8, 2016 Medical Communications, Sales and Marketing GSK, doctor payments, medical education, transparency

GSK has put into practice its pledge to halt payments to doctors to promote its products at medical seminars – …
News
Mylan building

Mylan announces Momenta collaboration to develop six biosimilars

January 8, 2016 Manufacturing and Production, Sales and Marketing Heather Bresch, Momenta, Mylan, biosimilars

Mylan has entered an exclusive global collaboration agreement with Momenta Pharmaceuticals, to develop, manufacture and commercialise six of Momenta’s biosimilar …
News
UK flag

Teva launches biosimilar fertility treatment in the UK

January 8, 2016 Manufacturing and Production, Sales and Marketing Ovaleap, Teva, biosimilar

Teva has launched its biosimilar version of Merck’s fertility treatment Gonal-f in the UK, potentially bringing a more affordable version …
News
Neil Woodford

Investment group renews calls for GSK to split

January 8, 2016 Medical Communications, Sales and Marketing GSK, Neil Woodford, investment, restructure

Multi-million pound fund manager Neil Woodford has renewed his call for GSK to break up into separate business units, amid …
News
Valeant logo

Why 2016 could be a make or break year for Valeant

January 8, 2016 Medical Communications, Sales and Marketing Howard Schiller, J. Michael Pearson, Michael Pearson, Valeant

This could prove a make-or-break year for Valeant.The specialist drug company begins 2016 with a reputation damaged by allegations of …
Feature
FDA sign

FDA review for Sanofi and Regeneron’s biologic arthritis drug

January 8, 2016 Medical Communications, Sales and Marketing FDA, Regeneron, Sanofi, biologics, rheumatoid arthritis, sarilumab

The FDA has accepted for review a Biologics License Application (BLA) from Sanofi and Regeneron for the rheumatoid arthritis treatment …
News
victoria_photo_feb_14

New head for AI drug discovery firm Molplex

January 7, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Molplex, Victoria Camargo

The artificial intelligence drug discovery company Molplex has appointed Victoria Camargo as its new chief executive. Camargo replaces the co-founder …
Appointment
Dr Reddy's generic nexium

Dr Reddy’s relaunches generic Nexium in blue after AstraZeneca lawsuit

January 6, 2016 Manufacturing and Production, Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, acid reflux, esomeprazole, lawsuit, purple pill

Dr Reddy’s has relaunched its generic version of AstraZeneca’s blockbuster heartburn drug Nexium  in the US, changing the colour from …
News
howard_schiller_valeant

Valeant names interim CEO in Pearson’s absence

January 6, 2016 Medical Communications, Sales and Marketing Valeant

Valeant has named company director Howard Schiller as interim chief executive officer to serve while full-time boss Michael Pearson is …
Appointment
afrezza_insulin

Sanofi abandons MannKind’s failed inhalable insulin

January 6, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Afrezza, Mannkind, Sanofi, insulin

Sanofi is to exit a licensing and co-marketing deal with MannKind for the inhalable insulin Afrezza, after disappointing sales figures …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026